Initial public offering of Orexo (SE) — SEK 333 million

Carnegie acted as joint lead manager and joint book-runner in the initial public offering of Orexo on the O-list of the Stockholm Stock Exchange. The offering, which consisted of 3.7 million newly issued shares, was fully subscribed. Orexo is a product based drug delivery company which develops proprietary pharmaceuticals to address areas of unmet therapeutic need. November, 2005.